细菌中Ⅰ型毒素-抗毒素系统的研究进展

毒素-抗毒素系统是广泛存在于细菌和真菌细胞内的一对小型遗传控制元件,毒素基因编码稳定的蛋白质分子,抗毒素基因编码的则是稳定性较差的蛋白质或者是具有调控功能的RNA.人们对于毒素分子在细胞内的生物靶标、分子结构与功能、体内调节机制等进行了大量的研究,不仅揭示了毒素-抗毒素的生理功能,而且为多种生物技术中的应用提供了新的素材.目前发现共有5大类型的毒素-抗毒素系统,其中Ⅰ型毒素-抗毒素系统的抗毒素分子为调节型RNA,可以通过多种不同途径与毒素蛋白质的mRNAs结合从而中和毒素的细胞毒性.Ⅰ型毒素-抗毒素系统以其独特的调节性RNA的调控方式,成为目前毒素-抗毒素研究中的重要热点.本文将对目前Ⅰ型毒素-抗毒素系统的研究进展进行综述,并对其可能的应用前景进行展望.     

细菌中I型毒素蛋白与细胞膜相互作用机制的研究进展

I型毒素-抗毒素（TA）系统在细菌基因组中广泛存在,在细菌的生长、生存中发挥多种生物学功能,包括抗菌、红细胞毒性、促进持留菌形成、抑制细菌生长或导致细菌休眠等。绝大部分I型毒素蛋白以细胞膜作为靶标,目前已知的一种作用机制是在细胞膜上形成孔洞结构,造成膜电位的下降或细胞膜的破坏,从而抑制ATP的合成或导致细菌死亡;另一种可能的作用机制是毒素蛋白作用在细胞膜上,改变细胞的形状,导致细胞进入休眠状态。I型毒素蛋白-细胞膜作用机制的复杂性和生物功能的多样性远超预期。因此,解析I型毒素蛋白在不同细胞膜中的组装机制及其所形成结构特征就变得非常重要,这也是揭示其结构-功能关系的关键。本文通过综述已报道的I型TA系统的结构特征与生物学功能,结合对其跨膜结构域的预测,探讨了其可能在细胞膜中形成的不同结构及其对功能的影响,分析了影响作用机制的关键因素。这些研究既给耐药细菌的治疗带来机遇,又为新型抗菌药物的研发带来思路。     

副溶血弧菌染色体上毒素-抗毒素系统YefM-YoeB的鉴定

【背景】副溶血弧菌是一种重要的食源性病原菌,给公众健康带来严重危害。毒素-抗毒素系统广泛存在于细菌和古生菌基因组中,具有重要的生物学功能。【目的】在副溶血弧菌中鉴定新的毒素-抗毒素系统,为从毒素-抗毒素系统角度探讨该菌致病性和耐药性的分子机制奠定基础。【方法】通过在线工具预测副溶血弧菌染色体上的假定II型毒素-抗毒素系统;通过生长曲线分析和稀释点板实验检测假定毒素对大肠杆菌的毒性作用及相应抗毒素的抗毒性作用;通过反转录PCR确定毒素和抗毒素基因是否共转录;通过生物信息学分析确定新鉴定毒素-抗毒素系统的同源蛋白;通过LacZ报告实验确定抗毒素及毒素-抗毒素复合物对自身启动子的调控作用。【结果】副溶血弧菌染色体中编码6个假定II型毒素-抗毒素系统;基因vp1820的表达产物(VP1820)对大肠杆菌具有杀菌活性,vp1821的表达产物(VP1821)能中和VP1820的毒性;基因vp1821和vp1820共转录;vp1821-vp1820编码YefM-YoeB毒素-抗毒素系统;抗毒素YefM正调控启动子,YefM-YoeB复合物负调控启动子。【结论】在副溶血弧菌中鉴定了一个新的II型毒素-抗毒素系统,即YefM-YoeB,为进一步研究该系统对副溶血弧菌致病性和耐药性的影响奠定了基础。     

毒素-抗毒素系统介导持留菌形成机制的研究进展

毒素-抗毒素(toxin-antitoxin,TA)系统是广泛存在细菌基因组上的由两个基因组成的操纵子,分别编码稳定的毒素蛋白和不稳定的抗毒素,其中毒素蛋白具有多种生物学功能。持留菌是指能够耐受高浓度抗生素或不利环境的一类细菌,它们同样具有TA系统。现就毒素-抗毒素系统介导持留菌形成机制的研究进展作一综述。     

Nat Microbiol:科学家开发出抵御细菌感染的新疗法

正在细菌中,毒素抗毒素系统包含着两个相互关联的基因,基因其位于相同的染色体上,其可以编码一种毒性蛋白和中和毒性的解毒蛋白;正常情况下,抗毒素蛋白会结合毒性蛋白并且抑制其发挥作用,但对环境压力产生反应时,抗毒素蛋白就会破碎,从而就使得细胞出现毒性作用。近日刊登于国际杂志Nature Microbiology上的一篇研究报告中,来自日内瓦大学的研究人员就对毒     

NOS结构及NOS氧化酶域与抑制剂络合的研究进展

ＮＯＳ氧化精氨酸生成ＮＯ,ＮＯ是一种信息分子和防御细胞毒素的效应分子。细胞因子诱导型ＮＯＳ氧化酶域（ｉＮＯＳｏｘ）具有独特的折叠方式及血红素周围结构。两个ＮＯＳ单元形成二聚体时,ＮＯＳ才具有活性,二聚体形成受蝶呤（Ｈ４Ｂ）结合的影响。咪唑（ＩＭ）及氨基胍结合位点的发现对药物设计具有重要意义,为寻找多位点结合抑制剂提供了研究方向。     

细菌毒素-抗毒素系统的研究进展

毒素-抗毒素系统(toxin-antitoxin system,TA)由两个共表达的基因组成,其中一个基因编码不稳定的抗毒素蛋白(antitoxin),另一个基因编码稳定的毒素蛋白(toxin).毒素-抗毒素系统最早发现于一些低拷贝的质粒,用来维持低拷贝质粒在菌群中的稳定存在.随后的研究表明,毒素-抗毒素系统广泛存在于细菌,包括一些致病菌的染色体上.在营养缺乏等不良生长条件下,由于基因表达的抑制和蛋白酶的降解作用,不稳定的抗毒素蛋白减少,从而产生游离的毒素蛋白,导致细菌的生长抑制和死亡.毒素-抗毒素系统的生理功能目前还存在争议,有学者认为细茼染色体上的毒素-抗毒素系统可以在不良生长状况下介导细菌的死亡,即细茼程序性细胞死亡(baeterial programmedcell death).但也有证据显示,毒素-抗毒素系统的功能更偏向于应激状态下的生理调节方面,即只起应激状态下的抑菌作用而不是杀菌作用.对细菌生长调控中毒素-抗毒素系统的作用机理进行综述,并探讨毒素-抗毒素系统研究的理论和应用价值.     

梭菌神经毒素分子作用机制的相关研究进展

厌氧梭菌产生的神经毒素可以引起严重的神经失调,甚至威胁生命.作为具有很高同源性的7种毒素分子,它们既具有相似的发病机制又有不尽相同的结构基础和分子作用方式,从而产生不同的毒素活性.主要就神经毒素分子作用机制相关的毒素蛋白结构、毒素受体、毒素活性的发生、毒素与底物的作用、底物的调节作用与应用等内容的研究进展作一综述.     

高致病性2型猪链球菌毒素-抗毒素系统SezAT的鉴定与活性研究

【目的】对我国高致病性2型猪链球菌05Z33基因组的89K毒力岛序列进行生物信息学分析,发现存在一对与化脓链球菌Epsilon-zeta(ε-ζ)同源的Ⅱ型毒素-抗毒素系统(Toxin-antitoxin system,TA)——SezAT,推测该系统具有稳定89K毒力岛使其不易丢失的作用。验证SezAT为有活性的TA系统。【方法】对SezAT进行了生物信息学分析;RT-PCR验证SezAT共转录特性;在大肠杆菌中选择性地诱导表达毒素蛋白SezT和抗毒素蛋白SezA;最后通过同源重组技术敲除SezAT系统。【结果】sezAT由同一操纵子控制,SezT可抑制细菌生长,SezA可中和SezT的毒性作用,同源重组成功获得sezT敲除突变株。【结论】证实SezAT为一对有活性的毒素-抗毒素(TA)系统,为进一步研究SezAT可能发挥稳定89K毒力岛的功能,同时获得89K毒力岛缺失突变株并深入认识89K在我国高致病性SS2中的作用奠定了基础。     

Structural Basis for Type VI Secretion Effector Recognition by a Cognate Immunity Protein

The type VI secretion system (T6SS) has emerged as an important mediator of interbacterial interactions. A T6SS from Pseudomonas aeruginosa targets at least three effector proteins, type VI secretion exported 1–3 (Tse1–3), to recipient Gram-negative cells. The Tse2 protein is a cytoplasmic effector that acts as a potent inhibitor of target cell proliferation, thus providing a pronounced fitness advantage for P. aeruginosa donor cells. P. aeruginosa utilizes a dedicated immunity protein, type VI secretion immunity 2 (Tsi2), to protect against endogenous and intercellularly-transferred Tse2. Here we show that Tse2 delivered by the T6SS efficiently induces quiescence, not death, within recipient cells. We demonstrate that despite direct interaction of Tsi2 and Tse2 in the cytoplasm, Tsi2 is dispensable for targeting the toxin to the secretory apparatus. To gain insights into the molecular basis of Tse2 immunity, we solved the 1.00 Å X-ray crystal structure of Tsi2. The structure shows that Tsi2 assembles as a dimer that does not resemble previously characterized immunity or antitoxin proteins. A genetic screen for Tsi2 mutants deficient in Tse2 interaction revealed an acidic patch distal to the Tsi2 homodimer interface that mediates toxin interaction and immunity. Consistent with this finding, we observed that destabilization of the Tsi2 dimer does not impact Tse2 interaction. The molecular insights into Tsi2 structure and function garnered from this study shed light on the mechanisms of T6 effector secretion, and indicate that the Tse2–Tsi2 effector–immunity pair has features distinguishing it from previously characterized toxin–immunity and toxin–antitoxin systems.     

Crystal structure of Pseudomonas aeruginosa Tsi2 reveals a stably folded superhelical antitoxin

In the competition for niches in natural resources, Pseudomonas aeruginosa utilizes the type VI secretion system to inject the toxic protein effector Tse2 into bacteria on cell–cell contact. The cytoplasm toxin immunity protein Tsi2 can neutralize Tse2 by physical interaction with the toxin, providing essential protection from toxin activity. Except for orthologues in P. aeruginosa, Tsi2 antitoxin does not share detectable sequence homology with known proteins in public databases. The mechanism underlying toxin neutralization by Tsi2 remains unknown. We report here the crystal structure of Tsi2 at 2.28 Å resolution. Our structural and biophysical analyses demonstrate that the antitoxin adopts a previously unobserved superhelical conformation. Tsi2 is highly thermostable in the absence of the toxin in solution. Tsi2 assembles a dimer with 2-fold rotational symmetry, similar to that observed in other toxin–antitoxin systems. Dimerization is essential for the stable folding of Tsi2.     

Structural Insights into the Pseudomonas aeruginosa Type VI Virulence Effector Tse1 Bacteriolysis and Self-protection Mechanisms

Recently, it was identified that Pseudomonas aeruginosa competes with rival cells to gain a growth advantage using a novel mechanism that includes two interrelated processes as follows: employing type VI secretion system (T6SS) virulence effectors to lyse other bacteria, and at the same time producing specialized immunity proteins to inactivate their cognate effectors for self-protection against mutual toxicity. To explore the structural basis of these processes in the context of functional performance, the crystal structures of the T6SS virulence effector Tse1 and its complex with the corresponding immunity protein Tsi1 were determined, which, in association with mutagenesis and Biacore analyses, provided a molecular platform to resolve the relevant structural questions. The results indicated that Tse1 features a papain-like structure and conserved catalytic site with distinct substrate-binding sites to hydrolyze its murein peptide substrate. The immunity protein Tsi1 interacts with Tse1 via a unique interactive recognition mode to shield Tse1 from its physiological substrate. These findings reveal both the structural mechanisms for bacteriolysis and the self-protection against the T6SS effector Tse1. These mechanisms are significant not only by contributing to a novel understanding of niche competition among bacteria but also in providing a structural basis for antibacterial agent design and the development of new strategies to fight P. aeruginosa.     

Crystal structure of type VI effector Tse1 from Pseudomonas aeruginosa

The type VI secretion systems (T6SS) have emerging roles in interspecies competition. In order to have an advantage in defense against other organisms, this system in Pseudomonas aeruginosa delivers a peptidoglycan amidase (Tse1) to the periplasmic space of a competitor. An immune protein (Tsi1) is also produced by the bacterium to protect itself from damage caused by Tse1. Tsi1 directly interacts with Tse1. We report that the crystal structure of Tse1 displays a common CHAP protein fold. Strikingly, our structures showed that the third residue in the catalytic triad may be novel as this residue type has not been observed previously.     

Structural insights into the T6SS effector protein Tse3 and the Tse3–Tsi3 complex from Pseudomonas aeruginosa reveal a calcium‐dependent membrane‐binding mechanism

The opportunistic pathogen Pseudomonas aeruginosa uses the type VI secretion system (T6SS) to deliver the muramidase Tse3 into the periplasm of rival bacteria to degrade their peptidoglycan (PG). Concomitantly, P. aeruginosa uses the periplasm‐localized immunity protein Tsi3 to prevent potential self‐intoxication caused by Tse3, and thus gains an edge over rival bacteria in fierce niche competition. Here, we report the crystal structures of Tse3 and the Tse3–Tsi3 complex. Tse3 contains an annexin repeat‐like fold at the N‐terminus and a G‐type lysozyme fold at the C‐terminus. One loop in the N‐terminal domain (Loop 12) and one helix (α9) from the C‐terminal domain together anchor Tse3 and the Tse3–Tsi3 complex to membrane in a calcium‐dependent manner in vitro, and this membrane‐binding ability is essential for Tse3's activity. In the C‐terminal domain, a Y‐shaped groove present on the surface likely serves as the PG binding site. Two calcium‐binding motifs are also observed in the groove and these are necessary for Tse3 activity. In the Tse3–Tsi3 structure, three loops of Tsi3 insert into the substrate‐binding groove of Tse3, and three calcium ions present at the interface of the complex are indispensable for the formation of the Tse3–Tsi3 complex.     

Structural Insights on the Bacteriolytic and Self-protection Mechanism of Muramidase Effector Tse3 in Pseudomonas aeruginosa

The warfare among microbial species as well as between pathogens and hosts is fierce, complicated, and continuous. In Pseudomonas aeruginosa, the muramidase effector Tse3 (Type VI secretion exported 3) can be injected into the periplasm of neighboring bacterial competitors by a Type VI secretion apparatus, eventually leading to cell lysis and death. However, P. aeruginosa protects itself from lysis by expressing immune protein Tsi3 (Type six secretion immunity 3). Here, we report the crystal structure of the Tse3-Tsi3 complex at 1.8 Å resolution, revealing that Tse3 possesses one open accessible, goose-type lysozyme-like domain with peptidoglycan hydrolysis activity. Calcium ions bind specifically in the Tse3 active site and are identified to be crucial for its bacteriolytic activity. In combination with biochemical studies, the structural basis of self-protection mechanism of Tsi3 is also elucidated, thus providing an understanding and new insights into the effectors of Type VI secretion system.     

Functional annotation of a novel toxin–antitoxin system Xn-RelT of <Emphasis Type="Italic">Xenorhabdus nematophila</Emphasis>; a combined in silico and in vitro approach

Toxin–antitoxin (TA) complexes play an important role in stress responses and programmed cell death in bacteria. The RelB-RelE toxin antitoxin system is well studied in Escherichia coli. In this study, we used combined in silico and in vitro approaches to study a novel Xn-RelT toxin from Xenorhabdus nematophila bearing its own antitoxin Xn-RelAT—a RelB homolog of E. coli. The structure for this toxin–antitoxin pair is yet unknown. We generated homology-based models of X. nematophila RelT toxin and antitoxin. The deduced models were further characterized for protein–nucleic acid, protein–protein interactions and gene ontology. A detrimental effect of recombinant Xn-RelT on host E. coli was determined through endogenous toxicity assay. When expressed from a isopropyl β-d-1-thiogalactopyranoside-regulated LacZ promoter, Xn-RelT toxin showed a toxic effect on E. coli cells. These observations imply that the conditional cooperativity governing the Xn-RelT TA operon in X. nematophila plays an important role in stress management and programmed cell death.